Inhibition of PPARα/γ by pharmaceutical means could induce EMT through PPAR signaling [46], which might explain that WY-14,643 suppressed ccRCC cell migration in the present study. The gene discussed is PPARA; the disease is nonpapillary renal cell carcinoma.